Page 226 - Aet News Today

Medical device manufacturer iCAD entered into a development and commercialization agreement with Google Health, in which it will integrate Google’s mammography AI technology into its suite of breast imaging AI products. The agreement marks Google’s first commercial partnership to deploy its breast imaging AI model into clinical practice.

Some industry experts seem skeptical of the rumored deal between Amwell and Talkspace, while others disagree. The rumored purchasing price is $200 million at about $1.50 per share.

Patient privacy is evolving rapidly in the post-Dobbs era, according to healthcare and life science lawyers in a webinar hosted by the American Bar Association on Wednesday. 

Thanks to the convergence of cloud technologies, AI, and refined lung data, we are in a new era for those with chronic lung disease. In this new world, lung intelligence provides fast, precision measures of treatment efficacy so new drugs can blaze through the trial pipeline.

People are living longer and this growing patient population needs innovative treatments tailored to the needs of aging bodies, which is why clinical research must include elderly patients.

In a webinar, flipMD and physicians discussed how the organization connects pioneering healthcare companies with expert physicians to maximize patient impact.

In the third quarter of 2022, BCBS Massachusetts’ members had about 8 million behavioral health visits, compared to about 4 million in 2019. In response, the insurer is expanding its mental health services by contracting with Talkiatry, And Still We Rise and DynamiCare.

As gene sequencing, machine learning, powerful imaging, sensors, gene and cell therapies make their way out of academic labs into everyday healthcare, our approach to healthcare is changing. For the first time, not only can we pinpoint the molecular and genetic causes of disease, but we also have the technologies to access them. On the back of this, prevention and cures are becoming possible. Can we afford them?

Dr. Akram Boutros said in a lawsuit filed Monday in Cuyahoga County court that Cleveland-based MetroHealth’s board of directors violated open meeting laws when it “secretly hired” counsel to investigate him and then terminated him without mandatory public notice. 

The funding round was led by Optum Ventures. Other investors include Adams Street Partners, Blue Shield of California and Humana. DispatchHealth will use the money to expand its capabilities in current markets, its CEO said.